These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 23039655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M, Martinov M, Thomson RM.
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [Abstract] [Full Text] [Related]

  • 5. Improved treatment planning for COMS eye plaques.
    Astrahan MA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1227-42. PubMed ID: 15752905
    [Abstract] [Full Text] [Related]

  • 6. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using 125I COMS plaques.
    Lee YC, Lin SC, Kim Y.
    Radiat Oncol; 2018 Nov 13; 13(1):221. PubMed ID: 30424782
    [Abstract] [Full Text] [Related]

  • 7. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H, Menon G, Larocque MP, van Veelen B, Niatsetski Y, Weis E, Sloboda RS.
    Med Phys; 2018 Jul 13; 45(7):3349-3360. PubMed ID: 29729009
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optic disc dose reduction in ocular brachytherapy using 125 I notched COMS plaques: A simulation study based on current clinical practice.
    Lee YC, Lin SC, Kim Y.
    J Appl Clin Med Phys; 2020 Sep 13; 21(9):57-70. PubMed ID: 32656945
    [Abstract] [Full Text] [Related]

  • 11. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
    Melhus CS, Rivard MJ.
    Med Phys; 2008 Jul 13; 35(7):3364-71. PubMed ID: 18697560
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
    Deufel CL, Furutani KM.
    Brachytherapy; 2015 Jul 13; 14(2):209-30. PubMed ID: 25533415
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
    Miras Del Río H, Ortiz Lora A, Bertolet Reina A, Terrón León JA.
    Med Phys; 2021 Aug 13; 48(8):4542-4559. PubMed ID: 34250607
    [Abstract] [Full Text] [Related]

  • 18. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
    Gagne NL, Leonard KL, Rivard MJ.
    Med Phys; 2012 Jun 13; 39(6):3332-42. PubMed ID: 22755715
    [Abstract] [Full Text] [Related]

  • 19. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
    Williamson JF, Butler W, Dewerd LA, Huq MS, Ibbott GS, Mitch MG, Nath R, Rivard MJ, Todor D, American Association of Physicists in Medicine.
    Med Phys; 2005 May 13; 32(5):1424-39. PubMed ID: 15984693
    [Abstract] [Full Text] [Related]

  • 20. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
    Johnson JE, Deufel CL, Furutani KM.
    Brachytherapy; 2016 May 13; 15(5):661-8. PubMed ID: 27475484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.